A detailed history of New Age Alpha Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 125,719 shares of BMY stock, worth $7.68 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
125,719
Holding current value
$7.68 Million
% of portfolio
0.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$51.92 - $59.94 $6.53 Million - $7.54 Million
125,719 New
125,719 $7.11 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $130B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New Age Alpha Advisors, LLC Portfolio

Follow New Age Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Age Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Age Alpha Advisors, LLC with notifications on news.